CJ Bioscience said on the 1st that it will take part in the 11th International Human Microbiome Consortium (IHMC) to share its research results. The event is an academic conference where about 1,000 people from academia, industry, and research gather to discuss the microbiome.
Microbiome refers to developing new drugs based on microorganisms that exist in the human body. CJ Bioscience is developing CJRB-201, a candidate treatment for intestinal diseases, using the microbiome. It plans to present nonclinical research results at this conference.
It will also share research on a personalized diet index that can predict gut microbial health based on usual eating habits. CJ Bioscience will develop a customized wellness business based on this.
The conference will be held at Coex in Gangnam-gu, Seoul, from the 3rd to the 5th. Ramnik Xavier, a Harvard Medical School professor, Ruth Ray of the Max Planck Institute, and Oh Beom-jo of the Department of Family Medicine at Boramae Medical Center will attend. A company official said, "We will seek recognition for our research and development data and diversify our business into health & wellness."